- Misonix (NASDAQ:MSON -4.6%) results:
- Fiscal Q4 results: Revenues: $5.6M (+48.4%); Gross Profit: $3.7M (+184.1%); Operating Expenses: $3.4M (-2.8%); Operating Income: $0.2M (+110.5%); Net Income: $1.4M (+190.6%); EPS: $0.18 (+181.8%); Quick Assets: $7.0M (+21.2%).
- Fiscal 2014 results: Revenues: $17.1M (+15.5%); Gross Profit: $11.1M (+50.0%); Operating Expenses: $13.7M (+7.5%); Operating Loss: ($2.5M) (+52.1%); Net Income: $1.4M (+152.2%); EPS: $0.19 (+50.0%).
- BoneScalpel units sold/consigned in Q4: 53 (+39.5%); full year: 190 (+37.7%).
- No financial guidance given.